BCDK1

Qiuni Chen1,2, Lei Xu1,2, Chuanyang Lu1,2

  • 1Department of Hematology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, 223300, Jiangsu Province, PR China.

BMC cancer
|January 8, 2025
PubMed
概括

升高的环素依赖激酶1 (CDK1) 水平表明扩散性大B细胞淋巴瘤 (DLBCL) 患者的预后较差. 这项研究发现CDK1是DLBCL结果的独立预测因子,抑制它可以减少癌细胞的生长.